Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marlen Hesse

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
MicroRNA maturation and human diseaseMarlen Hesse, Christoph Arenz
Expert Opinion on Therapeutic Patents|October 14, 2014
miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson's disease: a patent evaluation of WO2014018650Marlen Hesse, Christoph Arenz
Chembiochem : a European Journal of Chemical Biology|December 18, 2015
A Rapid and Versatile Assay for Ago2-Mediated Cleavage by Using Branched Rolling Circle AmplificationMarlen Hesse, Christoph Arenz
Chemical Communications (Cambridge, England)|March 12, 2013
A chemo-enzymatic approach to specifically click-modified RNAClaudine M Dojahn, Marlen Hesse, Christoph Arenz
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
Assaying Dicer-mediated miRNA maturation by means of fluorescent substratesMarlen Hesse, Brian P Davies, Christoph Arenz
European Journal of Pharmacology|December 25, 2013
Rotigotine protects against glutamate toxicity in primary dopaminergic cell cultureSandra Oster, Khaled Radad, Dieter Scheller, et al.
Antioxidants & Redox Signaling|January 25, 2011
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonismAgnieszka Jazwa, Ana I Rojo, Nadia G Innamorato, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
MicroRNA maturation and human diseaseMarlen Hesse, Christoph Arenz
Expert Opinion on Therapeutic Patents|October 14, 2014
miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson's disease: a patent evaluation of WO2014018650Marlen Hesse, Christoph Arenz
Chembiochem : a European Journal of Chemical Biology|December 18, 2015
A Rapid and Versatile Assay for Ago2-Mediated Cleavage by Using Branched Rolling Circle AmplificationMarlen Hesse, Christoph Arenz
Chemical Communications (Cambridge, England)|March 12, 2013
A chemo-enzymatic approach to specifically click-modified RNAClaudine M Dojahn, Marlen Hesse, Christoph Arenz
Methods in Molecular Biology (Clifton, N.J.)|October 30, 2013
Assaying Dicer-mediated miRNA maturation by means of fluorescent substratesMarlen Hesse, Brian P Davies, Christoph Arenz
European Journal of Pharmacology|December 25, 2013
Rotigotine protects against glutamate toxicity in primary dopaminergic cell cultureSandra Oster, Khaled Radad, Dieter Scheller, et al.
Antioxidants & Redox Signaling|January 25, 2011
Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonismAgnieszka Jazwa, Ana I Rojo, Nadia G Innamorato, et al.
Pageof 1